Quest Diagnostics Earnings & Forecasts

Quest Diagnostics (DGX) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Jul 23, 2026	$3.12	$2.82	10.6 %
Q1	Apr 21, 2026	$2.50	$2.36	5.93 %
Q4	Feb 10, 2026	$2.42	$2.35	2.98 %
Q3	Oct 21, 2025	$2.60	$2.51	3.59 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Jul 23, 2026	$3.04B	$2.97B	2.29 %
Q1	Apr 21, 2026	$2.90B	$2.82B	2.63 %
Q4	Feb 10, 2026	$2.81B	$2.76B	1.76 %
Q3	Oct 21, 2025	$2.82B	$2.73B	3.19 %

Quest Diagnostics Guidance

Quest Diagnostics (DGX)은 지난 7월 23, 2026에 fiscal year 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $11.05 - $11.25 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $10.76보다 높은 수치입니다. Quest Diagnostics는 또한 해당 기간의 매출을 $11.95B - $12.05B 범위로 전망했습니다.

이전 가이던스와 비교하여 Quest Diagnostics는 주당순이익(EPS) 전망치를 이전 범위인 상향 조정됨에서 $10.63 - $10.83로 상향 조정했습니다. 매출 측면에서는 회사가 매출 전망치를 이전 범위인 상향 조정됨에서 $11.78B - $11.9B로 상향 조정했습니다.

Quest Diagnostics은 18과 10월 20, 2022 사이에 7월 23, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 6 times and lowered it 1 time, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$2.82	$2.36	$2.35	$2.51
Actual	$3.12	$2.50	$2.42	$2.60
Surprise	+10.6%	+5.93%	+2.98%	+3.59%
Revenue
Estimate	$2.97B	$2.82B	$2.76B	$2.73B
Actual	$3.04B	$2.90B	$2.81B	$2.82B
Surprise	+2.29%	+2.63%	+1.76%	+3.19%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$2.86	$2.68	$2.76	$3.16
Revenue
Consensus	$3.04B	$3.01B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning

Quest Diagnostics (NYSE: DGX) stock jumps after Q2 earnings beat estimates and full-year 2026 guidance gets a boost.

Vandana Singh

Earnings Scheduled For July 23, 2026

Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is expected to report

Benzinga Insights

PRO
Quest Diagnostics Raises FY2026 Adj EPS Guidance from $10.63-$10.83 to $11.05-$11.25 vs $10.76 Est; Raises FY2026 Sales Guidance from $11.780B-$11.900B to $11.950B-$12.050B vs $11.851B Est

Quest Diagnostics (NYSE:DGX) raises FY2026 Adj EPS guidance from $10.63-$10.83 to $11.05-$11.25 vs $10.76 analyst estimate. Raises FY2026 sales outlook from $11.780 billion-$11.900 billion to $11.950 billion-$12.050

Benzinga Newsdesk

Quest Diagnostics Inc